SILICON VALLEY, WASHINGTON, DC, October 28, 2022: Morgan Lewis represented SeaStar Medical, Inc. in the completion of its previously announced business combination with LMF Acquisition Opportunities, Inc. The business combination closed on October 28, 2022.
SeaStar Medical is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. LMF Acquisition Opportunities is a special purpose acquisition company (SPAC) sponsored by LM Funding America Inc. Following the closing of the business combination, LMF Acquisition Opportunities was renamed SeaStar Medical Holding Corporation.
The Morgan Lewis team included partners Albert Lung and Erin Martin and associates Christopher Ronne, Esther Phu, Lixin Lin, David Bionghi, Jumpei Seto, Christina Wlodarczyk, Kristi Thielen, Udoka Okafor, Jessie Li, and Emily Chapman.